Skip to main content

FDA Approvals

FDA Approvals
Ponatinib: New Option for the Treatment of Adults with CML or Ph+ ALL that Is Resistant or Intolerant to Previous Therapy with Tyrosine Kinase Inhibitors
Lynne Lederman, PhD
Read More
FDA Approvals
Qsymia: Combination Oral Therapy a New Weight-Loss Option for Obese or Overweight Patients
... .. ...., ....
Read More
FDA Approvals
Belviq: A New Prescription Weight-Loss Treatment for Overweight or Obese Patients
... .. ...., ....
Read More
FDA Approvals
First-in-Class Angiotensin Receptor Neprilysin Inhibitor Promising in Heart Failure with Preserved Ejection Fraction
Mary Mosley
Read More
FDA Approvals
RELAX-AHF: Serelaxin Reduces Dyspnea in Acute Heart Failure
Mary Mosley
Read More
FDA Approvals
GLP-1 Agonism Holds Promise for Preventing Macrovascular Disease in Type 2 Diabetes
Wayne Kuznar
Read More
FDA Approvals
CVD Pipeline: Novel Approaches to Modifying Lipids/Lipoproteins
Mary Mosley
Read More
FDA Approvals
Payer Drug and Molecular Testing Utilization Policies
Charles Bankhead, Medical Writer
Read More
FDA Approvals
Empagliflozin Safe and Effective with or without Metformin, Reduces Weight
Mary Mosley
Read More
FDA Approvals
Lixisenatide Continues to Show Good Results in GetGoal Program Studies
Mary Mosley
Read More
Page 50 of 53
Results 491 - 500 of 528